NO20050149D0 - Fremgangmate ved behandling av iskemisk reperfusjonsskade ved anvendelse av adenosinreseptor-antagonister - Google Patents

Fremgangmate ved behandling av iskemisk reperfusjonsskade ved anvendelse av adenosinreseptor-antagonister

Info

Publication number
NO20050149D0
NO20050149D0 NO20050149A NO20050149A NO20050149D0 NO 20050149 D0 NO20050149 D0 NO 20050149D0 NO 20050149 A NO20050149 A NO 20050149A NO 20050149 A NO20050149 A NO 20050149A NO 20050149 D0 NO20050149 D0 NO 20050149D0
Authority
NO
Norway
Prior art keywords
progress
receptor antagonists
reperfusion injury
adenosine receptor
ischemic reperfusion
Prior art date
Application number
NO20050149A
Other languages
English (en)
Other versions
NO20050149L (no
Inventor
Glenn J Smits
Xiaowei Jin
Garrett J Gross
John Auchampach
Original Assignee
Mcw Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcw Res Found Inc filed Critical Mcw Res Found Inc
Publication of NO20050149D0 publication Critical patent/NO20050149D0/no
Publication of NO20050149L publication Critical patent/NO20050149L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20050149A 2002-06-12 2005-01-11 Fremgangmate ved behandling av iskemisk reperfusjonsskade ved anvendelse av adenosinreseptor-antagonister NO20050149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38868002P 2002-06-12 2002-06-12
PCT/US2003/018695 WO2003105666A2 (en) 2002-06-12 2003-06-12 Method of treating ischemia reperfusion injury using adenosine receptor antagonists

Publications (2)

Publication Number Publication Date
NO20050149D0 true NO20050149D0 (no) 2005-01-11
NO20050149L NO20050149L (no) 2005-03-11

Family

ID=29736516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050149A NO20050149L (no) 2002-06-12 2005-01-11 Fremgangmate ved behandling av iskemisk reperfusjonsskade ved anvendelse av adenosinreseptor-antagonister

Country Status (18)

Country Link
US (1) US20050203065A1 (no)
EP (1) EP1513848A4 (no)
JP (1) JP2005533054A (no)
CN (1) CN1671716A (no)
AU (1) AU2003236509A1 (no)
BR (1) BR0312137A (no)
CA (1) CA2489179A1 (no)
EA (1) EA200500005A1 (no)
IS (1) IS7592A (no)
MX (1) MXPA04012629A (no)
NO (1) NO20050149L (no)
NZ (1) NZ537444A (no)
PL (1) PL374498A1 (no)
RS (1) RS107404A (no)
SG (1) SG131115A1 (no)
UA (1) UA84404C2 (no)
WO (1) WO2003105666A2 (no)
ZA (1) ZA200500254B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035142A2 (en) 2001-10-25 2003-05-01 Emory University Catheter for modified perfusion
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
CA2592142A1 (en) * 2004-12-22 2006-06-29 Emory University Therapeutic adjuncts to enhance the organ protective effects of postconditioning
WO2006099958A1 (en) * 2005-03-24 2006-09-28 Bayer Healthcare Ag Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage
ES2270715B1 (es) 2005-07-29 2008-04-01 Laboratorios Almirall S.A. Nuevos derivados de pirazina.
TW201402124A (zh) * 2005-08-19 2014-01-16 Array Biopharma Inc 作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
ES2274712B1 (es) 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
DE102006046410A1 (de) * 2006-09-20 2008-03-27 Eberhard-Karls-Universität Tübingen Universitätsklinikum Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von ischämischen Krankheiten
US20100063071A1 (en) * 2008-06-13 2010-03-11 Kiesman William F Therapeutic compositions and related methods of use
AR085942A1 (es) * 2011-04-07 2013-11-06 Gilead Sciences Inc Uso de receptor de aadenosina para tratar la insuficiencia cardiaca y la arritmia en pacientes posinfarto de miocardio
JP5162727B2 (ja) * 2011-04-12 2013-03-13 株式会社 資生堂 美白剤およびメラニン生成抑制剤
CN102274232B (zh) * 2011-06-22 2013-03-27 南京理工大学 腺苷受体a1拮抗剂在制备药物中的应用
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
EP2970172B1 (en) * 2013-03-14 2019-10-30 Bristol-Myers Squibb Company Bicyclo [2.2.2]acid gpr120 modulators
JP2023533016A (ja) 2020-07-11 2023-08-01 ファイザー・インク 抗ウイルス性ヘテロアリールケトン誘導体
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
WO1995011681A1 (en) * 1993-10-29 1995-05-04 Merck & Co., Inc. Human adenosine receptor antagonists
US5733916A (en) * 1995-03-24 1998-03-31 The Trustees Of The University Of Pennsylvania Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
US6303619B1 (en) * 1998-03-12 2001-10-16 University Of Virginia Meta-substituted acidic 8-phenylxanthine antagonists of A3 human adenosine receptors
DE19816857A1 (de) * 1998-04-16 1999-10-21 Boehringer Ingelheim Pharma Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6187780B1 (en) * 1998-04-16 2001-02-13 Boehringer Ingelheim Pharma Kg Assymetrically substituted xanthine derivatives having adenosine A1 antagonistic activity
HUP0203371A3 (en) * 1999-11-12 2005-02-28 Biogen Idec Ma Inc Cambridge Adenosine receptor antagonists and methods of making and using the same
CN100390178C (zh) * 1999-11-12 2008-05-28 拜奥根Idec马萨诸塞公司 作为腺苷受体拮抗剂的多环烷基嘌呤
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease

Also Published As

Publication number Publication date
RS107404A (sr) 2007-02-05
IS7592A (is) 2004-12-10
PL374498A1 (en) 2005-10-31
NZ537444A (en) 2006-09-29
BR0312137A (pt) 2005-04-05
AU2003236509A1 (en) 2003-12-31
ZA200500254B (en) 2006-04-26
CA2489179A1 (en) 2003-12-24
WO2003105666A2 (en) 2003-12-24
US20050203065A1 (en) 2005-09-15
WO2003105666A3 (en) 2004-09-16
SG131115A1 (en) 2007-04-26
UA84404C2 (ru) 2008-10-27
JP2005533054A (ja) 2005-11-04
NO20050149L (no) 2005-03-11
EP1513848A2 (en) 2005-03-16
EA200500005A1 (ru) 2005-06-30
CN1671716A (zh) 2005-09-21
EP1513848A4 (en) 2005-11-09
MXPA04012629A (es) 2005-10-18

Similar Documents

Publication Publication Date Title
NO20050149D0 (no) Fremgangmate ved behandling av iskemisk reperfusjonsskade ved anvendelse av adenosinreseptor-antagonister
DE602005020127D1 (de) Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors
ATE293627T1 (de) Adenosin a2a rezeptor antagonisten
DE60209251D1 (de) Adenosine a2a receptor antagonisten
DE60234951D1 (de) Adenosin a2a rezeptor antagonisten
EP1807966A4 (en) AUTHENTICATION METHOD
DE60013558D1 (de) Fräswerkzeug zum fräsen in bohrlöchern
NO20032277L (no) Aminotiazoler og deres anvendelse som adenosinreseptorantagonister
DE50307129D1 (de) Aza-bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
IL175759A0 (en) A2b adenosine receptor antagonists
DE502004002597D1 (de) Handbetriebene Vorrichtung zum Spalten von Holz
DE60024584D1 (de) Vorrichtung zum gebrauch bei der überprüfung des sehvermögens
DE50114462D1 (de) Verstellbare Arbeitsbühne
DE602005013307D1 (de) Vorrichtung zum Umdrehen von sich bewegenden Flaschen
FR2808469B1 (fr) Machine portative pour chanfreiner des pierres
HK1076103A (en) Method of treating ischemia reperfusion injury using adenosine receptor antagonists
FI20020140A0 (fi) Hiihto-, kõvely- tai luistelusauvan kõdensija ja siihen kiinnitetty kõsihihna
DE602005014924D1 (de) Vibrations-Gleitschleifapparat
DE50312833D1 (de) Einrichtung zum stapeln flacher sendungen in eine stapelaufnahme
DE502004003116D1 (de) Vorrichtung zum Schneiden von Wärmedämmplatten
FR2862898B3 (fr) Cle reglable
FR2854451B3 (fr) Appareil de sechage de materiau en forme de blocs, notamment de briques
ATA82299A (de) Vorrichtung zum trocknen von holz, insbesondere schnittholz
NO20032730L (no) Anordning til bruk ved sammenkopling av store konstruksjoner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application